{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T11:56:49Z","timestamp":1771675009086,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005897","name":"Soci\u00e9t\u00e9 Fran\u00e7aise de Dermatologie et de Pathologie Sexuellement Transmissible","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.annder.2022.01.001","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T08:56:22Z","timestamp":1644915382000},"page":"169-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["CITY-PSO: Prescribing behaviour of French private-practice dermatologists in psoriasis management: An observational, multicentre, cross-sectional study"],"prefix":"10.1016","volume":"149","author":[{"given":"J.-M.","family":"Amici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bergqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Corgibet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-F.","family":"Se\u00ef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Seneschal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Sbidian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Beylot-Barry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2022.01.001_bib0115","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2133.2006.07405.x","article-title":"European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey","volume":"155","author":"Dubertret","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2022.01.001_bib0120","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/bjd.19169","article-title":"Global psoriasis atlas. Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender","volume":"184","author":"Iskandar","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2022.01.001_bib0125","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/jdv.15340","article-title":"Psoriasis Research Group of the French Society of Dermatology. French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults","volume":"33","author":"Amatore","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.01.001_bib0130","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(19)31772-6","article-title":"Psoriasis biologics: a new era of choice","volume":"394","author":"Mahil","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.annder.2022.01.001_bib0135","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/jdv.14406","article-title":"Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohort","volume":"31","author":"Sbidian","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.01.001_bib0140","first-page":"310","article-title":"Do psoriasis patients seen in private practice differ from those seen in hospitals?","volume":"147","author":"de la Br\u00e9t\u00e8que","year":"2020","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.01.001_bib0145","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/bjd.20384","article-title":"Soci\u00e9t\u00e9 Fran\u00e7aise de Photodermatologie. Decline in the use of phototherapy in France from 2010 to 2019","volume":"185","author":"Aubin","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2022.01.001_bib0150","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/jdv.16566","article-title":"Epidemiologic study in a real-world analysis of patients with treatment for psoriasis in the French national health insurance database","volume":"35","author":"Grodner","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.01.001_bib0155","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/bjd.19169","article-title":"Global Psoriasis Atlas. Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender","volume":"184","author":"Iskandar","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2022.01.001_bib0160","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2022.01.001_bib0165","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.clindermatol.2007.10.026","article-title":"Psoriasis treatment in difficult locations: scalp, nails, and intertriginous areas","volume":"26","author":"Wozel","year":"2008","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.annder.2022.01.001_bib0170","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","article-title":"Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics","volume":"69","author":"Mease","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2022.01.001_bib0175","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/j.1468-3083.2008.02841.x","article-title":"Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry","volume":"22","author":"Nast","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.01.001_bib0180","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jamadermatol.2013.5264","article-title":"Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003\u20132011","volume":"149","author":"Armstrong","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.annder.2022.01.001_bib0185","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1111\/jdv.13150","article-title":"Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey","volume":"29","author":"van de Kerkhof","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.01.001_bib0190","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.det.2016.03.004","article-title":"Psoriasis trends and practice gaps","volume":"34","author":"Gottlieb","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.annder.2022.01.001_bib0195","first-page":"805","article-title":"Essential truths for the care and management of moderate-to-severe psoriasis","volume":"14","author":"Blauvelt","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.annder.2022.01.001_bib0200","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1368-5031.2005.00680.x","article-title":"Current management of psoriasis in the United Kingdom: patterns of prescribing and resource use in primary care","volume":"59","author":"Gillard","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.annder.2022.01.001_bib0205","doi-asserted-by":"crossref","first-page":"e747","DOI":"10.1111\/jdv.16601","article-title":"Impact of the French guidelines on the prescribing habits of systemic treatments for moderate-to-severe psoriasis","volume":"34","author":"Villani","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.01.001_bib0210","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00403-009-0978-y","article-title":"Do guidelines change the way we treat? Studying prescription behaviour among private practitioners before and after the publication of the German Psoriasis Guidelines","volume":"301","author":"Nast","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.annder.2022.01.001_bib0215","first-page":"520","article-title":"Groupe de recherche sur le psoriasis de la Societe Francaise de Dermatologie. Private-hospital network: Organisation of joint private-hospital follow-up","volume":"146","author":"Le Maitre","year":"2019","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2022.01.001_bib0220","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2133.2012.10991.x","article-title":"Significant delay in the introduction of systemic treatment of moderate to severe psoriasis: a prospective multicentre observational study in outpatients from hospital dermatology departments in France","volume":"167","author":"Maza","year":"2012","journal-title":"Br J Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963822000011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963822000011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:10:20Z","timestamp":1758971420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963822000011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0151963822000011"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2022.01.001","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CITY-PSO: Prescribing behaviour of French private-practice dermatologists in psoriasis management: An observational, multicentre, cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2022.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}